Teva Pharmaceuticals Usa

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Tamsulosin
First Posted Date
2010-06-23
Last Posted Date
2010-06-23
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
32
Registration Number
NCT01149746
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

First Posted Date
2010-06-23
Last Posted Date
2010-12-08
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
20
Registration Number
NCT01149486
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Tamsulosin
First Posted Date
2010-06-23
Last Posted Date
2024-08-20
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
32
Registration Number
NCT01149733
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Valacyclovir 1000 mg Tablet Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Valacyclovir
First Posted Date
2010-06-23
Last Posted Date
2010-06-23
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
60
Registration Number
NCT01149499
Locations
🇺🇸

PRACS Institute, Ltd., East Grand Forks, Minnesota, United States

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Losartan potassium/Hydrochlorothiazide
First Posted Date
2010-06-23
Last Posted Date
2024-08-20
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
80
Registration Number
NCT01149473
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Valacyclovir 1000 mg Tablet Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Valacyclovir
First Posted Date
2010-06-23
Last Posted Date
2024-08-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
36
Registration Number
NCT01149460
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cozaar®
Drug: Losartan
First Posted Date
2010-05-14
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
80
Registration Number
NCT01124175
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cozaar®
Drug: Losartan
First Posted Date
2010-05-14
Last Posted Date
2010-12-08
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
80
Registration Number
NCT01124162
Locations
🇨🇦

Anapharm Inc., Montreal, Quebec, Canada

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Pramipexole Dihydrochloride
First Posted Date
2010-02-24
Last Posted Date
2010-04-30
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT01074450
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Pramipexole Dihydrochloride
First Posted Date
2010-02-24
Last Posted Date
2010-04-30
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT01074463
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy